InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Wednesday, 11/30/2022 8:14:49 PM

Wednesday, November 30, 2022 8:14:49 PM

Post# of 462100
I have to laugh at those who think Anavex would even be allowed to present Bad News in a highly coveted ORAL presentation at the CTAD Conference! And why would Anavex want to? I hope everyone has seen the recent Guggenheim presentation. The slide about Catalysts to Drive Value (15) speaks of a "potentially pivotal Phase 2b/3 AD clinical trial" reporting. Even double blinded trials can reveal obvious benefits to researchers! Looking forward to Dec. 1 and have added bargain shares.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News